Delivery Order SPE2DB20D3103-SPE2DB24FL9C5

Award Date 12/13/23
Potential Completion Date 12/14/23
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,733.85 firm-fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product, to support the U.S. government's healthcare needs. The contract has an ultimate completion date of December 7, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier of medical products to the federal government. The contract is a Delivery Order valued at $1,656.72 and is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,279.30 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The award has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,225.44 firm fixed price delivery order to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
This federal contract award, valued at $2,034.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,138.61 firm fixed price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a prescription medication. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) between DLA and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,152.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
The U.S. Defense Logistics Agency (DLA) awarded a $7,638.75 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment programs...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,500.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,091.82 firm fixed-price delivery order covers the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a critical pharmaceutical product, with a period of performance through November 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FL9C5
    Delivery Order

This federal contract award between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract, valued at $1,633.92, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs.

Generated 2/27/25, 9:44 AM